{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:16:18Z","timestamp":1780506978279,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.antiviral.2013.09.019","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T09:16:14Z","timestamp":1383297374000},"page":"S25-S31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"S","title":["Lessons from reproductive health to inform multipurpose prevention technologies: Don\u2019t reinvent the wheel"],"prefix":"10.1016","volume":"100","author":[{"given":"Martha","family":"Brady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.09.019_b0005","unstructured":"Askew, I., Brady, M., 2013. The Unfinished Agenda to Meet FP2020: 12 Actions to Fill Critical Evidence Gaps. Population Council, New York."},{"key":"10.1016\/j.antiviral.2013.09.019_b0010","series-title":"Total Market Initiatives For Reproductive Health","author":"Barnes","year":"2012"},{"issue":"5","key":"10.1016\/j.antiviral.2013.09.019_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1287\/mnsc.15.5.215","article-title":"A new product growth model for consumer durables","volume":"15","author":"Bass","year":"1969","journal-title":"Management Science"},{"key":"10.1016\/j.antiviral.2013.09.019_b0020","series-title":"Constructing a Critical Path for Product Development, Commercialization and Access","author":"Brady","year":"2011"},{"key":"10.1016\/j.antiviral.2013.09.019_b0025","series-title":"Insights and Evidence from Product Introduction: Lessons for Microbicides","author":"Brady","year":"2007"},{"key":"10.1016\/j.antiviral.2013.09.019_b0030","series-title":"What Regulatory Guidance Exists for Multipurpose Prevention Technologies (MPTs)? A Review of Key Guidance Documents and their Applicability to MPTs","author":"Brady","year":"2011"},{"key":"10.1016\/j.antiviral.2013.09.019_b0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0010-7824(01)00204-9","article-title":"Assessing the acceptability, service delivery requirements and useeffectiveness of the diaphragm in Colombia, Philippines and Turkey","volume":"63","author":"Bulut","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.019_b0040","series-title":"Contraceptive Technologies: Responding to Women\u2019s Needs","author":"Darroch","year":"2011"},{"key":"10.1016\/j.antiviral.2013.09.019_b0045","series-title":"Commercialization of Products for \u201ctaboo\u201d Health Areas: An industry Perspective. Presented at Day of Dialogue: Insights and Evidence From Product Introbution: Lessons for Microbicides","author":"Feringa","year":"2007"},{"key":"10.1016\/j.antiviral.2013.09.019_b0050","series-title":"Access: How do Good Health Technologies Get to Poor People in Poor Countries?","author":"Frost","year":"2008"},{"key":"10.1016\/j.antiviral.2013.09.019_b0055","unstructured":"International Federation of Gynecology & Obstetrics (FIGO)\/International Consortium for Emergency Contraception (ICEC), 2012. Emergency contraceptive pills. Medical and service delivery guidelines."},{"issue":"S1","key":"10.1016\/j.antiviral.2013.09.019_b0060","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.ijgo.2013.02.005","article-title":"Meeting the need for modern contraception: effective solutions to a pressing global challenge","volume":"121","author":"Jacobstein","year":"2013","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"6","key":"10.1016\/j.antiviral.2013.09.019_b0065","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/COH.0b013e3283590632","article-title":"Acceptability in microbicides and PrEP trials: current status and reconceptualization","volume":"7","author":"Mensch","year":"2012","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"6","key":"10.1016\/j.antiviral.2013.09.019_b0070","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/09540120701693974","article-title":"The role of partnership dynamics in determining the acceptability of condoms and microbicides","volume":"20","author":"Montgomery","year":"2008","journal-title":"AIDS Care"},{"issue":"2","key":"10.1016\/j.antiviral.2013.09.019_b0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10461-007-9266-z","article-title":"Assessing microbicide acceptability: a comprehensive and integrated approach","volume":"12","author":"Morrow","year":"2008","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.antiviral.2013.09.019_b0080","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.contraception.2010.05.016","article-title":"Progesterone vaginal ring for contraceptive use during lactation","volume":"82","author":"Nath","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.019_b0085","unstructured":"Nel, A. et al., 2011. Safety and acceptability of silicone elastomer vaginal rings as potential microbicide delivery method in African women. Poster No: 1004, presented at CROI, Boston, Feb. 27\u2013Mar. 2, 2011."},{"key":"10.1016\/j.antiviral.2013.09.019_b0090","unstructured":"PATH and UNFPA, 2006. Female Condom: A Powerful Tool for Protection. UNFPA, PATH, Seattle, Washington. Available from: <http:\/\/www.unfpa.org\/upload\/lib_pub_file\/617_filename_female_condom.pdf>."},{"key":"10.1016\/j.antiviral.2013.09.019_b0095","series-title":"Access: How do Good Health Technologies Get to Poor People in Poor Countries?","article-title":"Female condoms: access to dual protection technologies","author":"Pratt","year":"2008"},{"key":"10.1016\/j.antiviral.2013.09.019_b0100","series-title":"Diffusion of Innovations","isbn-type":"print","author":"Rogers","year":"1962","ISBN":"https:\/\/id.crossref.org\/isbn\/0612628434"},{"key":"10.1016\/j.antiviral.2013.09.019_b0105","series-title":"Nonclinical Development Needs and Regulatory Requirements for Multipurpose Prevention Technologies: A Primer","author":"Romano","year":"2012"},{"key":"10.1016\/j.antiviral.2013.09.019_b0110","series-title":"Adding it Up: Costs and Benefits of Contraceptive Services \u2013 Estimates for 2012","author":"Singh","year":"2012"},{"key":"10.1016\/j.antiviral.2013.09.019_b0115","unstructured":"UNDP\/UNFPA\/WHO\/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, 1994. Contraceptive introduction reconsidered: a review and conceptual framework. WHO\/HRP\/ITT \/94.1."},{"key":"10.1016\/j.antiviral.2013.09.019_b0125","series-title":"Maternal, Nutrition, Child Health Fact Sheet","author":"USAID","year":"2010"},{"issue":"21","key":"10.1016\/j.antiviral.2013.09.019_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0968-8080(03)02178-5","article-title":"Expanding safer sex options: introducing the female condom into national programmes","volume":"11","author":"Warren","year":"2003","journal-title":"Reproductive Health Matters"},{"issue":"4","key":"10.1016\/j.antiviral.2013.09.019_b0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2471\/BLT.10.077446","article-title":"Emergency contraception: dispelling the myths and misperceptions","volume":"88","author":"Westley","year":"2010","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.antiviral.2013.09.019_b0140","series-title":"The Female Condom: A Review","author":"WHO","year":"1997"},{"key":"10.1016\/j.antiviral.2013.09.019_b0145","unstructured":"WHO, 2010. Fact sheet on the safety of levonorgestrel-alone emergency contraceptive pills (LNG ECPs) Available from: <http:\/\/www.cecinfo.org\/publications-and-resources\/icec-publications\/>. Accessed May 21, 2013."},{"key":"10.1016\/j.antiviral.2013.09.019_b0150","series-title":"Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections-2008: Overview and Estimates","author":"WHO","year":"2012"},{"key":"10.1016\/j.antiviral.2013.09.019_b0155","unstructured":"WHO, 2013. Family Planning. Fact sheet No. 351. Available from: <http:\/\/www.who.int\/mediacentre\/factsheets\/fs351\/en\/>. Accessed May 15, 2013."},{"key":"10.1016\/j.antiviral.2013.09.019_b0165","series-title":"Provider-Related Barriers to Accessing Emergency Contraception in Developing Countries: A Literature Review","author":"Williams","year":"2011"},{"issue":"2","key":"10.1016\/j.antiviral.2013.09.019_b0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1521\/aeap.2008.20.2.171","article-title":"Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi","volume":"20","author":"Woodsong","year":"2008","journal-title":"AIDS Education and Prevention"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T23:24:23Z","timestamp":1539213863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213002672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":32,"alternative-id":["S0166354213002672"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.019","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons from reproductive health to inform multipurpose prevention technologies: Don\u2019t reinvent the wheel","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}